Hyro Secures $45M in Growth Funding to Expand AI Agents for Healthcare

Hyro, an artificial intelligence company specializing in healthcare solutions, has raised $45 million in a strategic growth round, positioning itself as the "Responsible AI Agent Platform" for the healthcare industry. This latest funding nearly doubles the company's total capital and valuation, signaling strong investor confidence in Hyro's AI-driven approach to improving patient care and operational efficiency in healthcare systems.

Funding Details and Strategic Investors

The growth round, situated between Hyro's series B and C rounds, was led by Healthier Capital, a venture fund founded by One Medical's Amir Dan Rubin. Other participants included Norwest, Define Ventures, and notably, Bon Secours Mercy Health, a five-year client of Hyro. ServiceNow Ventures, the investment arm of ServiceNow, also joined the round, further diversifying Hyro's investor base.

Israel Krush, CEO and co-founder of Hyro, emphasized the significance of this funding: "This new funding round reflects the industry's growing trust in our approach. With support from both new strategic investors and long-time partners, we're well-positioned to expand across new specialties and segments throughout the healthcare ecosystem."

Expansion of AI Capabilities and Market Presence

Hyro plans to utilize the new capital to accelerate the development of additional AI agents, focusing on administrative, clinical, and operational functions within healthcare settings. The company's platform is currently deployed across 45 hospital systems, engaging with over 30 million patients through voice and chat interfaces.

A key differentiator for Hyro is its healthcare-specific knowledge, multi-modal data ingestion capabilities, understanding of healthcare workflows, and integration with major electronic medical record systems like Epic. The company reports that its AI agents can resolve up to 85% of routine patient needs, including registration, routing, scheduling, and prescription management.

Industry Impact and Future Outlook

The investment in Hyro comes at a time when the healthcare industry is increasingly adopting AI solutions to enhance patient care and streamline operations. Amir Dan Rubin, CEO and founding managing partner of Healthier Capital, commented on Hyro's potential: "Hyro is delivering better levels of access, experience, and operational performance to leading healthcare organizations, delivering significant returns-on-investment."

As Hyro continues to expand its reach beyond large hospital systems to health plans and mid-sized clinics, the company is poised to play a significant role in shaping the future of AI-assisted healthcare delivery. The successful funding round and growing client base suggest that Hyro's responsible AI approach is resonating with both investors and healthcare providers alike.